ASA maintained its positive momentum throughout 2024 to meet imperative goals for the continued success of the Strategic Revenue Growth Initiative. ASA focused on graduating concepts through the Idea Development Cycle (IDC) to launch non-dues revenue-bearing assets into the marketplace.
- Initiated PeRLS Expansion: Delivered key product enhancements to support institutional purchasing and implementation, aligning the PeRLS solution with ALS requirements.
- Executed Strategic PeRLS Marketing and Sales: Launched targeted campaigns for chairs and department heads of anesthesiology, securing new four-year contracts with the University of Chicago and the University of Illinois at Chicago.
- Advanced Product Portfolio: Successfully guided six projects through various phases of the IDC process.
